What is it about?
Non-invasive prenatal screening is being expanded to look at all possible large chromosome imbalances. However, many of these are only present in the placenta and are not present in the fetus. Their clinical significance is often unclear. We consider how often these might be encountered, additional testing required, and counseling difficulties associated with their discovery.
Featured Image
Read the Original
This page is a summary of: Genome‐wide non‐invasive prenatal screening for all cytogenetically visible imbalances, Ultrasound in Obstetrics and Gynecology, April 2018, Wiley,
DOI: 10.1002/uog.19014.
You can read the full text:
Contributors
The following have contributed to this page